ATE411393T1 - P75ntr-screeningtest zur identifizierung von modulatoren der apoptose - Google Patents

P75ntr-screeningtest zur identifizierung von modulatoren der apoptose

Info

Publication number
ATE411393T1
ATE411393T1 AT05766804T AT05766804T ATE411393T1 AT E411393 T1 ATE411393 T1 AT E411393T1 AT 05766804 T AT05766804 T AT 05766804T AT 05766804 T AT05766804 T AT 05766804T AT E411393 T1 ATE411393 T1 AT E411393T1
Authority
AT
Austria
Prior art keywords
apoptosis
p75ntr
screening test
identify modulators
test compound
Prior art date
Application number
AT05766804T
Other languages
English (en)
Inventor
Wouter Bruinzeel
Miroslav Cik
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE411393T1 publication Critical patent/ATE411393T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05766804T 2004-07-14 2005-07-11 P75ntr-screeningtest zur identifizierung von modulatoren der apoptose ATE411393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103368 2004-07-14
US58855104P 2004-07-16 2004-07-16

Publications (1)

Publication Number Publication Date
ATE411393T1 true ATE411393T1 (de) 2008-10-15

Family

ID=39243741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05766804T ATE411393T1 (de) 2004-07-14 2005-07-11 P75ntr-screeningtest zur identifizierung von modulatoren der apoptose

Country Status (9)

Country Link
US (1) US8637464B2 (de)
EP (1) EP1771572B1 (de)
AT (1) ATE411393T1 (de)
AU (1) AU2005261721B2 (de)
CA (1) CA2571130C (de)
DE (1) DE602005010436D1 (de)
DK (1) DK1771572T3 (de)
ES (1) ES2315889T3 (de)
WO (1) WO2006005740A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011163241A2 (en) * 2010-06-21 2011-12-29 Georgetown University Neuroprotective compounds
WO2014049556A2 (en) * 2012-09-28 2014-04-03 The University Of Queensland Neurotrophin-tyrosine kinase receptor signaling
EP2950095B1 (de) * 2014-05-28 2018-08-29 Technische Universität Dresden Zellenbasierte Test- und Screeningverfahren auf Modulatoren von p75NTR-Signalisierung
IT202000007720A1 (it) * 2020-04-10 2021-10-10 Alessandra Marconi Peptidi e loro usi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2185535C (en) * 1994-04-11 2000-10-24 Christiaan Peter Maria Reutelingsperger A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
DE69939593D1 (de) * 1998-10-06 2008-10-30 Univ Queensland St Lucia Polypeptide zur modulierung des überlebens von zellen
FR2801320B1 (fr) * 1999-11-19 2002-02-15 Inst Nat Sante Rech Med Procede d'evaluation de la genotoxicite d'un compose
AU2001228212A1 (en) 2000-01-18 2001-07-31 Mcgill University Beta-turn peptidomimetic cyclic compounds

Also Published As

Publication number Publication date
EP1771572B1 (de) 2008-10-15
DE602005010436D1 (de) 2008-11-27
CA2571130A1 (en) 2006-01-19
DK1771572T3 (da) 2009-02-16
AU2005261721A1 (en) 2006-01-19
WO2006005740A2 (en) 2006-01-19
WO2006005740A3 (en) 2006-06-29
CA2571130C (en) 2014-08-19
ES2315889T3 (es) 2009-04-01
AU2005261721B2 (en) 2011-02-24
EP1771572A2 (de) 2007-04-11
US20080064036A1 (en) 2008-03-13
US8637464B2 (en) 2014-01-28

Similar Documents

Publication Publication Date Title
WO2002087306A3 (en) High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
DE69430573T2 (de) Test und reagentien zur identifizierung von antiproliferierenden stoffen
ATE382060T1 (de) Moleküle und verfahren zur inhibierung der freisetzung von kim-1
ATE411393T1 (de) P75ntr-screeningtest zur identifizierung von modulatoren der apoptose
ATE269974T1 (de) Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
ATE513833T1 (de) Thienopyridinverbindungen und verfahren zu ihrer verwendung
ES2539411T3 (es) PD-1, receptor para la B7-4 y su utilización
HK1102197A1 (en) Hif prolyl hydroxylase activity assay
ATE346168T1 (de) Funktionelles oberflächendisplay von polypeptiden
ATE382148T1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
DE69739898D1 (de) Tests auf proteinkinasen mit fluoreszierenden proteinsubstraten
ATE254660T1 (de) Methode zur markierung von eukaryotischen zellen mittels verwendung von rezeptoren der zelloberfläche als marker
MXPA04001287A (es) Ensayo de receptor unido a proteina g.
WO2006028576A3 (en) Determination of a phosphorylation site in ppiase domain of pin1 and uses therefor
ATE354635T1 (de) Substrat und verfahren zum messen elektrophysiologischer eigenschaften von zellmembranen
MXPA03011898A (es) Ensayo de seleccion in vitro para ?- secretasa.
DE60107416D1 (de) Adnf mischungen zur verbesserung der lernfähigkeit und der gedächtnisfunktion
ATE404692T1 (de) Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen.
ATE540966T1 (de) Von phenoxazinon abgeleitete neue enzymsubstrate und deren verwendung als entwickler bei der detektion von mikroorganismen mit peptidaseaktivität
Kaufmann et al. Thrombin receptor activation results in calcium signaling and protein kinase C‐dependent stimulation of DNA synthesis in HEp‐2g laryngeal carcinoma cells
ATE520024T1 (de) Patch-clamp-verfahren und seine verwendung zur untersuchung subzellulärer merkmale
ATE469238T1 (de) Verwendung von fluor-nmr zum screening mit hohem durchsatz
Kikkawa et al. Maintenance of hepatic differentiation by hepatocyte attachment peptides derived from laminin chains

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties